tetano
Editor, Senior Moderator
PeerJ
. 2022 Jun 14;10:e13437.
doi: 10.7717/peerj.13437. eCollection 2022.
Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis
Jacqueline Betsabe Puicón-Suárez[SUP] 1 [/SUP], Sandra Zeña-Ñañez[SUP] 2 [/SUP], Virgilio E Failoc-Rojas[SUP] 3 4 [/SUP]
Affiliations
Abstract
Objective: To determine the association between chronic kidney disease (CKD) and mortality in persons with a confirmed coronavirus disease 2019 (COVID-19) diagnosis.
Methods: Cross-sectional secondary baseline study. The study population consisted of 243,065 patients confirmed to have COVID-19 during May-December 2020. Stata 16.0 was used for statistical analysis, Chi-square test was used for bivariate analysis, and Poisson regression with robust variances was used for multiple analysis.
Results: The prevalence of patients with a confirmed COVID-19 diagnosis who had CKD and died was 1.42 times the prevalence of mortality in those without CKD. The comorbidities combined with CKD that presented the highest probability of mortality were diabetes mellitus and hypertension.
Conclusions: CKD is associated with a high mortality rate in patients with a confirmed COVID-19 diagnosis. Patients with CKD, diabetes mellitus, and arterial hypertension have a higher prevalence of mortality than those without comorbidities.
Keywords: COVID-19; Chronic kidney disease; Mexico; Mortality.
. 2022 Jun 14;10:e13437.
doi: 10.7717/peerj.13437. eCollection 2022.
Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis
Jacqueline Betsabe Puicón-Suárez[SUP] 1 [/SUP], Sandra Zeña-Ñañez[SUP] 2 [/SUP], Virgilio E Failoc-Rojas[SUP] 3 4 [/SUP]
Affiliations
- PMID: 35722260
- PMCID: PMC9205307
- DOI: 10.7717/peerj.13437
Abstract
Objective: To determine the association between chronic kidney disease (CKD) and mortality in persons with a confirmed coronavirus disease 2019 (COVID-19) diagnosis.
Methods: Cross-sectional secondary baseline study. The study population consisted of 243,065 patients confirmed to have COVID-19 during May-December 2020. Stata 16.0 was used for statistical analysis, Chi-square test was used for bivariate analysis, and Poisson regression with robust variances was used for multiple analysis.
Results: The prevalence of patients with a confirmed COVID-19 diagnosis who had CKD and died was 1.42 times the prevalence of mortality in those without CKD. The comorbidities combined with CKD that presented the highest probability of mortality were diabetes mellitus and hypertension.
Conclusions: CKD is associated with a high mortality rate in patients with a confirmed COVID-19 diagnosis. Patients with CKD, diabetes mellitus, and arterial hypertension have a higher prevalence of mortality than those without comorbidities.
Keywords: COVID-19; Chronic kidney disease; Mexico; Mortality.